Vis enkel innførsel

dc.contributor.authorYurchenko, Mariya
dc.contributor.authorSkjesol, Astrid
dc.contributor.authorRyan, Liv
dc.contributor.authorRichard, Gabriel Mary
dc.contributor.authorKandasamy, Richard Kumaran
dc.contributor.authorWang, Ninghai
dc.contributor.authorTerhorst, Cox
dc.contributor.authorHusebye, Harald
dc.contributor.authorEspevik, Terje
dc.date.accessioned2018-02-28T06:48:06Z
dc.date.available2018-02-28T06:48:06Z
dc.date.created2018-02-27T09:27:21Z
dc.date.issued2018
dc.identifier.citationJournal of Cell Biology. 2018, .nb_NO
dc.identifier.issn0021-9525
dc.identifier.urihttp://hdl.handle.net/11250/2487510
dc.description.abstractSignaling lymphocytic activation molecule family 1 (SLAMF1) is an Ig-like receptor and a costimulatory molecule that initiates signal transduction networks in a variety of immune cells. In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon β (IFNβ) and for killing of Gram-negative bacteria by human macrophages. We found that SLAMF1 controls trafficking of the Toll receptor–associated molecule (TRAM) from the endocytic recycling compartment (ERC) to Escherichia coli phagosomes. In resting macrophages, SLAMF1 is localized to ERC, but upon addition of E. coli, it is trafficked together with TRAM from ERC to E. coli phagosomes in a Rab11-dependent manner. We found that endogenous SLAMF1 protein interacted with TRAM and defined key interaction domains as amino acids 68 to 95 of TRAM as well as 15 C-terminal amino acids of SLAMF1. Interestingly, the SLAMF1–TRAM interaction was observed for human but not mouse proteins. Overall, our observations suggest that SLAMF1 is a new target for modulation of TLR4–TRAM–TRIF inflammatory signaling in human cells.nb_NO
dc.language.isoengnb_NO
dc.publisherRockefeller University Pressnb_NO
dc.titleSLAMF1 is required for TLR4-mediated TRAM-TRIF dependent signaling in human macrophagesnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionacceptedVersionnb_NO
dc.source.pagenumber19nb_NO
dc.source.journalJournal of Cell Biologynb_NO
dc.identifier.doi10.1083/jcb.201707027
dc.identifier.cristin1568941
dc.relation.projectNorges forskningsråd: 223255nb_NO
dc.description.localcode© 2018. This is the authors' accepted and refereed manuscript to the article. The final authenticated version is available online at: http://jcb.rupress.org/content/early/2018/02/09/jcb.201707027nb_NO
cristin.unitcode194,65,15,0
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.ispublishedtrue
cristin.fulltextpreprint
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel